用户名:
密 码:
注册
|
忘记密码?
首 页
药品信息
药品检索
全部药品
适应症分类
热门药品
专利信息
专利检索
专利权人导航
专利权人分组导航
分类查询
IPC导航
热门检索
专利分析
概况
申请趋势分析
申请人分析
发明人分析
IPC分析
项目文档
项目
个人项目
文档
个人文档
企业文档
公共文档
标签
互动
特色功能
广州科技订制咨询
特色资讯
医药新闻
帮助中心
关于本软件
药品
文档
专利
新闻
所有专利
选择导航
专利权人导航
专利权人分组导航
分类导航
专利权人导航
ASTRAZENECA AB(1316)
UNIV ABERDEEN(2)
KRONSTROM ANDERS(2)
MATTSON ANDERS(2)
MOLLER EVA(1)
LEANDER EVA(1)
DAHLSTROM MIKAEL(1)
COTTON HANNA(1)
专利信息
Translation Company
查询条件
展开筛选条件
[专利权人] 包含 'ASTRAZENECA AB'
清空条件
查询
分析
排序
公开日
公开号
申请日
申请号
中文标题
英文标题
降序
升序
翻到页码
标题
标题2
专利权人
发明人
附图
摘要
摘要2
优先权号
IPC
专利类型
首页
上页
1
2
3
4
5
6
7
8
9
10
11
下页
尾页
共
1316
条记录, 当前第6/132页。
公开号
公开日
申请号
申请日
1.
AT541838T
2012/2/15
专利标题
:Neue zur synthese von s- und r-omeprazol geeignete verbindungen und ein verfahren zu deren herstellung
专利权人
:
ASTRAZENECA AB
;
2.
MX2011013467A
2012/2/13
MX20110013467
2011/12/13
专利标题
:Method for treating a patient at risk for developing an nsaid-associated ulcer.
专利权人
:
ASTRAZENECA AB
;
The present disclosure is directed to a method for treating a disease or disorder in a patient at risk of developing an NSAID-associated ulcer by administering a pharmaceutical composition in unit dose form comprising naproxen or pharmaceutically acceptable salt thereof and esomeprazole or pharmaceutically acceptable salt thereof. The unit dose is designed to release at least a part of the esomeprazole independent of pH (e.g. at a pH of 0 or more) whereas the naproxen is not released until the p...
3.
AU2010263304A1
2012/2/2
AU20100263304
2010/6/23
专利标题
:Method for treating a patient at risk for developing an nsaid-associated ulcer
专利权人
:
ASTRAZENECA AB
;
The present disclosure is directed to a method for treating a disease or disorder in a patient at risk of developing an NSAID-associated ulcer by administering a pharmaceutical composition in unit dose form comprising naproxen or pharmaceutically acceptable salt thereof and esomeprazole or pharmaceutically acceptable salt thereof. The unit dose is designed to release at least a part of the esomeprazole independent of pH (e.g. at a pH of 0 or more) whereas the naproxen is not released until the p...
4.
AU2010270050A1
2012/2/2
AU20100270050
2010/7/5
专利标题
:Intermediates and processes for the preparation of 4- (acetylamino) ) -3- [ (4-chloro-phenyl) thio] -2-methyl-1H-indole-1-acetic acid
专利权人
:
ASTRAZENECA AB
;
The invention relates to compounds of formula (X), and salts thereof, and their use as intermediates in improved manufacturing processes for the synthesis of pharmaceutical compound of formula (I): X is =0, =N-0H or =N-OC(O)Me
5.
CN101115744B
2012/2/1
专利标题
:Method, midbody and the crystalline salt thereof of preparation 4-(6-chloro-2,3-methylenedioxyphenyl amido)-7-[2-(4-n-methyl piperazine-1-yl) oxyethyl group]-5-tetrahydropyran-4-base oxygen base quinazoline
专利权人
:
ASTRAZENECA AB
;
6.
CU20110133A7
2012/1/31
专利标题
:Derivados de (4-terc-butilpiperazin-2-il)(piperazin-1-il)metanona-n-carboxamida
专利权人
:
ASTRAZENECA AB
;
La presente invención se refiere a compuestos de fórmula (I) ESPACIO PARA LA FÓRMULA Los compuestos actúan a través del antagonismo del receptor CCR2b y pueden utilizarse para tratar una enfermedad inflamatoria y/o el dolor neuropático.
7.
EP1781631B1
2012/1/25
专利标题
:Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
专利权人
:
ASTRAZENECA AB
;
8.
EP1718636B1
2012/1/18
EP20050711081
2005/2/17
专利标题
:New compounds useful for the synthesis of s- and r-omeprazole and a process for their preparation
专利权人
:
ASTRAZENECA AB
;
The present invention relates to an improved method for the synthesis of the (S)- or (R)- enantiomer of omeprazole characterized in that 2-[[(4-X-35-dimethylpyridin-2-yl)methyl]thio]-5-methoxy-1H-benzimidazole or 2-[[(4-X-35-dimethyl-1-oxidopyridin-2-yl)methyl]thio]-5-methoxy-1H-benzimidazole wherein X is a leaving group is oxidized into the corresponding sulphoxide which is obtained as a crystalline compound. Recrystallisation of the thus obtained sulphoxide results in a compound of enhanced ch...
9.
NZ578159A
2012/1/12
NZ20070578159
2007/12/3
专利标题
:Antibacterial polycyclic urea compounds
专利权人
:
ASTRAZENECA AB
;
Disclosed are pyridine or pyrimidine amide derivatives of a compound of general formula (XVIII) wherein the other substituents are disclosed within the specification. Also disclosed is the use of the compounds for treating an antibacterial infection such as community-acquired pneumoniae hospital-acquired pneumoniae skin and skin structure infections acute exacerbation of chronic bronchitis acute sinusitis acute otitis media catheter related sepsis febrile neutropenia osteomyelitis endocarditis u...
10.
CN102317273A
2012/1/11
专利标题
:(4-tertiary butyl piperazine-2-yl) (piperazine-1-yl) ketone-n-carboxamides derivatives
专利权人
:
ASTRAZENECA AB
;
首页
上页
1
2
3
4
5
6
7
8
9
10
11
下页
尾页
共
1316
条记录, 当前第6/132页。
当前查询条件: [专利权人] 包含 'ASTRAZENECA AB'
查询范围
在当前结果中查询
!
专利类型
发明
实用新型
外观设计
!
公开号
CN1234
!
申请号
CN1234
!
专利标题
扩展
PHARMA
!
专利权人
扩展
pfizer
发明人
!
申请日
yyyymmdd
!
公开日
yyyymmdd
优先权号
!
摘要
扩展
PHARMA
IPC
A01B
下载范围
下载第
到
条记录。
下载内容
题录信息
专利全文